about
Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoningUsing glutamate homeostasis as a target for treating addictive disordersThe influence of N-acetyl-L-cystein infusion on cytokine levels and gastric intramucosal pH during severe sepsisN-acetylcysteine negatively regulates Notch3 and its malignant signalingThe role of cystine-glutamate exchange in nicotine dependence in rats and humansDeaths from low dose paracetamol poisoning. Executive action is needed to change national guidelinesAcetaminophen intoxication during treatment: what you don't know can hurt you.Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity.Glutamate transporter GLT-1 mediates N-acetylcysteine inhibition of cocaine reinstatement.N-acetylcysteine inhibits muscle fatigue in humansN-acetylcysteine in handgrip exercise: plasma thiols and adverse reactions.Anti-oxidant therapy: does it have a role in the treatment of human disease?N-acetyl cysteine therapy in acute viral hepatitis.Anti-inflammatory effects of Myrtol standardized and other essential oils on alveolar macrophages from patients with chronic obstructive pulmonary disease.Quercitrin from Toona sinensis (Juss.) M.Roem. Attenuates Acetaminophen-Induced Acute Liver Toxicity in HepG2 Cells and Mice through Induction of Antioxidant Machinery and Inhibition of Inflammation.N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking.Adverse reactions associated with acetylcysteine.A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment.The 100 most influential publications in paracetamol poisoning treatment: a bibliometric analysis of human studies.Protective effects of N-acetylcysteine against cadmium-induced damage in cultured rat normal liver cells.Adverse reactions to intravenous N-acetylcysteine in Chinese patients with paracetamol (acetaminophen) poisoning.N-acetylcysteine protects striated muscle in a model of compartment syndrome.Protective Effect of N-Acetyl-Cysteine (NAC) in Lipopolysaccharide (LPS)-Associated Inflammatory Response in Rat Neonates.Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review.Melatonin and N- Acetylcysteine as Remedies for Tramadol-Induced Hepatotoxicity in Albino Rats.New recommendation for N-acetylcystiene dosing may reduce incidence of adverse effects.The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock.Effect of three n-acetylamino acids on N-(3,5-dichlorophenyl)succinimide (NDPS) and ndps metabolite nephrotoxicity in Fischer 344 rats.N-acetylcysteine as salvage therapy in cisplatin nephrotoxicity.Cardiac arrest following therapeutic administration of N-acetylcysteine for paracetamol overdose.Pharmacokinetics of 2-oxothiazolidine-4-carboxylate, a cysteine prodrug, and cysteine.Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion.Antioxidant and free radical scavenging properties of N-acetylcysteine amide (NACA) and comparison with N-acetylcysteine (NAC).Respiratory loading intensity and diaphragm oxidative stress: N-acetyl-cysteine effects.Paracetamol-induced nephrotoxicity and oxidative stress in rats: the protective role of Nigella sativa.Applications of Synthetic Organic Tetrasulfides as H2S Donors.Recent advances in the management of late paracetamol poisoning
P2860
Q24564978-10A9EBCB-A058-4344-AAA7-7A7EBB3CA97DQ24619198-219CCC23-5A40-4E72-B415-AB53EB4414E3Q24800533-2C431998-41DD-48A4-8B8A-E8B146E6E020Q28391353-3428EB78-2F64-4BAA-AAE8-A783DE9A53EEQ28566669-D5D2A328-A910-46CA-B03B-B83DF68312C2Q33792954-47172122-F1A4-47F0-AB64-B645AC8C8AC8Q33883973-B08E75AA-F0AC-4D3E-AD88-143FCE126ABFQ34120596-CB6DEEC5-4EC9-41FC-9A5B-597C04502EEEQ35623912-29477201-3C01-4CE7-977E-A2583AEB3616Q35824683-A6C24D8F-229A-4681-8090-0049C4529E0DQ36029026-21B05F36-FF39-45A3-8513-975D58F49874Q36179770-8A635515-FB83-460F-A24C-43C6E2DDE403Q36180480-1707D058-C1CF-428C-93EF-F02FA81D63A7Q36464070-923A7714-A9C2-4CA8-92DE-6E135442D168Q37133104-3916D568-C952-4BA3-AF95-F0A44E3A0D39Q37259319-17E7D15D-ED78-4323-A880-897036842E44Q37413080-A87D6893-E564-4B70-97F1-B55E7D741CD5Q37476975-CDB0F05E-6FB5-4627-8E92-6AAB179C5EEEQ39367617-89E49384-DEB9-4D8E-83DC-BA669442E190Q39624873-E92F9E29-2F57-46C1-A1EB-8F6885EB11C5Q40697981-07099695-5546-4827-A3EA-1BADC2800EC3Q42053416-31BB3008-8E40-4B34-82CC-BCECECDFF1BBQ42289772-0202AECA-0133-4491-A78A-C2EA522BB298Q42540215-BAF94A96-2926-49C4-8D3E-D021A2BC8DC0Q42658247-5314360F-5D9E-47B6-934C-489E7AD11F43Q43245812-A4671628-9FCF-475F-8FA7-AB1AAC88981BQ43948790-4E9D0B4D-5946-43ED-AFFC-A4304532B590Q43951692-231373B1-924D-4F2F-BC15-CE650B68C586Q44126017-F471E26C-34C8-425D-9E7D-9302B1D54378Q46371798-2019474F-67DC-4734-AAB0-16B492D64598Q46444304-16AE4C03-6550-4650-B39D-4B9F4020EF7BQ46504384-180CB681-A534-43D3-907B-CE539D6A97FBQ46650704-BCCDAE02-81F5-4318-A0EE-7A3A777D15AAQ46728831-8D710E08-8536-4E80-AB21-ABFB2A86B871Q50921810-1161042F-FE65-4FCA-B61A-3801A1C2EF0CQ53335172-95FBFC0F-6E2D-46E7-ACDA-E9E46A0ABF4CQ57311326-13132D51-10D5-423E-A708-A26528756CC0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of N-acetylcysteine in clinical toxicology.
@en
Use of N-acetylcysteine in clinical toxicology.
@nl
type
label
Use of N-acetylcysteine in clinical toxicology.
@en
Use of N-acetylcysteine in clinical toxicology.
@nl
prefLabel
Use of N-acetylcysteine in clinical toxicology.
@en
Use of N-acetylcysteine in clinical toxicology.
@nl
P1476
Use of N-acetylcysteine in clinical toxicology.
@en
P2093
Flanagan RJ
Meredith TJ
P304
P356
10.1016/0002-9343(91)90296-A
P407
P577
1991-09-01T00:00:00Z